{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T02:26:27Z","timestamp":1789007187934,"version":"build-2803163510"},"reference-count":72,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1124\/jpet.121.000735","type":"journal-article","created":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T15:30:14Z","timestamp":1627659014000},"page":"74-84","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Metabotropic Glutamate Receptor 2\/3 Activation Improves Motor Performance and Reduces Pathology in Heterozygous zQ175 Huntington Disease Mice"],"prefix":"10.1016","volume":"379","author":[{"given":"Si Han","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tash-Lynn L.","family":"Colson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled S.","family":"Abd-Elrahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen S.G.","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.121.000735_bib1","doi-asserted-by":"crossref","first-page":"eabd2494","DOI":"10.1126\/scisignal.abd2494","article-title":"A\u03b2 oligomers induce pathophysiological mGluR5 signaling in Alzheimer\u2019s disease model mice in a sex-selective manner","volume":"13","author":"Abd-Elrahman","year":"2020","journal-title":"Sci Signal"},{"key":"10.1124\/jpet.121.000735_bib2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13041-019-0456-1","article-title":"Modulation of mTOR and CREB pathways following mGluR5 blockade contribute to improved Huntington\u2019s pathology in zQ175 mice","volume":"12","author":"Abd-Elrahman","year":"2019","journal-title":"Mol Brain"},{"key":"10.1124\/jpet.121.000735_bib3","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1021\/acsptsci.0c00013","article-title":"mGluR5 contribution to neuropathology in Alzheimer mice is disease stage-dependent","volume":"3","author":"Abd-Elrahman","year":"2020","journal-title":"ACS Pharmacol Transl Sci"},{"key":"10.1124\/jpet.121.000735_bib4","doi-asserted-by":"crossref","first-page":"eaan6387","DOI":"10.1126\/scisignal.aan6387","article-title":"mGluR5 antagonism increases autophagy and prevents disease progression in the zQ175 mouse model of Huntington\u2019s disease","volume":"10","author":"Abd-Elrahman","year":"2017","journal-title":"Sci Signal"},{"key":"10.1124\/jpet.121.000735_bib5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13041-018-0364-9","article-title":"Autophagy is increased following either pharmacological or genetic silencing of mGluR5 signaling in Alzheimer\u2019s disease mouse models","volume":"11","author":"Abd-Elrahman","year":"2018","journal-title":"Mol Brain"},{"key":"10.1124\/jpet.121.000735_bib6","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/ng0893-398","article-title":"The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington\u2019s disease","volume":"4","author":"Andrew","year":"1993","journal-title":"Nat Genet"},{"key":"10.1124\/jpet.121.000735_bib7","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/j.1471-4159.2007.04487.x","article-title":"Glutamate release from activated microglia requires the oxidative burst and lipid peroxidation","volume":"101","author":"Barger","year":"2007","journal-title":"J Neurochem"},{"key":"10.1124\/jpet.121.000735_bib8","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0014-2999(98)00551-2","article-title":"Selective activation of group-II metabotropic glutamate receptors is protective against excitotoxic neuronal death","volume":"356","author":"Battaglia","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.121.000735_bib9","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0028-3908(03)00146-1","article-title":"Protective role of group-II metabotropic glutamate receptors against nigro-striatal degeneration induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice","volume":"45","author":"Battaglia","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.121.000735_bib10","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.nbd.2014.11.012","article-title":"Activation of mGlu3 metabotropic glutamate receptors enhances GDNF and GLT-1 formation in the spinal cord and rescues motor neurons in the SOD-1 mouse model of amyotrophic lateral sclerosis","volume":"74","author":"Battaglia","year":"2015","journal-title":"Neurobiol Dis"},{"key":"10.1124\/jpet.121.000735_bib11","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1523\/JNEUROSCI.11-06-01649.1991","article-title":"Chronic quinolinic acid lesions in rats closely resemble Huntington\u2019s disease","volume":"11","author":"Beal","year":"1991","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.121.000735_bib12","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1146\/annurev.pharmtox.011008.145634","article-title":"Akt\/GSK3 signaling in the action of psychotropic drugs","volume":"49","author":"Beaulieu","year":"2009","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/jpet.121.000735_bib13","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1093\/brain\/awf180","article-title":"Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation","volume":"125","author":"Behrens","year":"2002","journal-title":"Brain"},{"key":"10.1124\/jpet.121.000735_bib14","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1084\/jem.20080178","article-title":"A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington\u2019s disease","volume":"205","author":"Bj\u00f6rkqvist","year":"2008","journal-title":"J Exp Med"},{"key":"10.1124\/jpet.121.000735_bib15","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1093\/hmg\/ddn159","article-title":"Sex differences in a transgenic rat model of Huntington\u2019s disease: decreased 17\u03b2-estradiol levels correlate with reduced numbers of DARPP32+ neurons in males","volume":"17","author":"Bode","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1124\/jpet.121.000735_bib16","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1097\/00001756-200506210-00026","article-title":"The novel mGluR2\/3 agonist LY379268 attenuates cue-induced reinstatement of heroin seeking","volume":"16","author":"Bossert","year":"2005","journal-title":"Neuroreport"},{"key":"10.1124\/jpet.121.000735_bib17","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1460-9568.1996.tb01174.x","article-title":"DCG-IV selectively attenuates rapidly triggered NMDA-induced neurotoxicity in cortical neurons","volume":"8","author":"Buisson","year":"1996","journal-title":"Eur J Neurosci"},{"key":"10.1124\/jpet.121.000735_bib18","doi-asserted-by":"crossref","first-page":"6480","DOI":"10.1073\/pnas.95.11.6480","article-title":"Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene","volume":"95","author":"Cha","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.121.000735_bib19","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1146\/annurev.pharmtox.37.1.205","article-title":"Pharmacology and functions of metabotropic glutamate receptors","volume":"37","author":"Conn","year":"1997","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/jpet.121.000735_bib20","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.drudis.2014.02.014","article-title":"The many faces of autophagy dysfunction in Huntington\u2019s disease: From mechanism to therapy","volume":"19","author":"Cortes","year":"2014","journal-title":"Drug Discov Today"},{"key":"10.1124\/jpet.121.000735_bib21","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.nbd.2018.08.010","article-title":"A role for autophagy in Huntington\u2019s disease","volume":"122","author":"Croce","year":"2019","journal-title":"Neurobiol Dis"},{"key":"10.1124\/jpet.121.000735_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00213-012-2921-8","article-title":"Serotonin-glutamate and serotonin-dopamine reciprocal interactions as putative molecular targets for novel antipsychotic treatments: From receptor heterodimers to postsynaptic scaffolding and effector proteins","volume":"225","author":"De Bartolomeis","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.121.000735_bib23","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13041-020-00657-7","article-title":"mGluR5 regulates REST\/NRSF signaling through N-cadherin\/\u03b2-catenin complex in Huntington\u2019s disease","volume":"13","author":"de Souza","year":"2020","journal-title":"Mol Brain"},{"key":"10.1124\/jpet.121.000735_bib24","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain","volume":"277","author":"DiFiglia","year":"1997","journal-title":"Science"},{"key":"10.1124\/jpet.121.000735_bib25","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bbr.2006.12.004","article-title":"Sex differences in behavior and striatal ascorbate release in the 140 CAG knock-in mouse model of Huntington\u2019s disease","volume":"178","author":"Dorner","year":"2007","journal-title":"Behav Brain Res"},{"key":"10.1124\/jpet.121.000735_bib26","doi-asserted-by":"crossref","first-page":"13571","DOI":"10.1038\/ncomms13571","article-title":"Transduction of group I mGluR-mediated synaptic plasticity by \u03b2-arrestin2 signalling","volume":"7","author":"Eng","year":"2016","journal-title":"Nat Commun"},{"key":"10.1124\/jpet.121.000735_bib27","doi-asserted-by":"crossref","first-page":"10928","DOI":"10.1523\/JNEUROSCI.2491-09.2009","article-title":"Interaction of postsynaptic density protein-95 with NMDA receptors influences excitotoxicity in the yeast artificial chromosome mouse model of Huntington\u2019s disease","volume":"29","author":"Fan","year":"2009","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.121.000735_bib28","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/ana.410390120","article-title":"Relationship between trinucleotide repeats and neuropathological changes in Huntington\u2019s disease","volume":"39","author":"Furtado","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1124\/jpet.121.000735_bib29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-1-4939-9658-2_3","article-title":"Physiology of Microglia","volume":"2034","author":"Garaschuk","year":"2019","journal-title":"Methods in Mol Bio"},{"key":"10.1124\/jpet.121.000735_bib30","doi-asserted-by":"crossref","first-page":"50514","DOI":"10.1074\/jbc.M309348200","article-title":"Enhanced Akt signaling is an early pro-survival response that reflects N-methyl-D-aspartate receptor activation in Huntington\u2019s disease knock-in striatal cells","volume":"278","author":"Gines","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.121.000735_bib31","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.tins.2004.08.011","article-title":"Homer-PIKE complex: a novel link between mGluRI and PI 3-kinase","volume":"27","author":"Guhan","year":"2004","journal-title":"Trends Neurosci"},{"key":"10.1124\/jpet.121.000735_bib32","doi-asserted-by":"crossref","first-page":"109361","DOI":"10.1016\/j.cellsig.2019.109361","article-title":"Structural determinants governing \u03b2-arrestin2 interaction with PDZ proteins and recruitment to CRFR1","volume":"63","author":"Gupta","year":"2019","journal-title":"Cell Signal"},{"key":"10.1124\/jpet.121.000735_bib33","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s11064-007-9463-1","article-title":"Glutamate uptake is reduced in prefrontal cortex in Huntington\u2019s disease","volume":"33","author":"Hassel","year":"2008","journal-title":"Neurochem Res"},{"key":"10.1124\/jpet.121.000735_bib34","doi-asserted-by":"crossref","first-page":"e50717","DOI":"10.1371\/journal.pone.0050717","article-title":"Characterization of neurophysiological and behavioral changes, MRI brain volumetry and 1H MRS in zQ175 knock-in mouse model of Huntington\u2019s disease","volume":"7","author":"Heikkinen","year":"2012","journal-title":"PLoS One"},{"key":"10.1124\/jpet.121.000735_bib35","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1523\/JNEUROSCI.5599-08.2009","article-title":"In vivo evidence for NMDA receptor-mediated excitotoxicity in a murine genetic model of Huntington disease","volume":"29","author":"Heng","year":"2009","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.121.000735_bib36","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/mdc3.13178","article-title":"Sex Differences in Huntington\u2019s disease: evaluating the Enroll-HD database","volume":"8","author":"Hentosh","year":"2021","journal-title":"Mov Disord Clin Pract"},{"key":"10.1124\/jpet.121.000735_bib37","doi-asserted-by":"crossref","first-page":"49577","DOI":"10.1074\/jbc.M111227200","article-title":"ERK1\/2 antagonizes glycogen synthase kinase-3\u03b2-induced apoptosis in cortical neurons","volume":"277","author":"Hetman","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.121.000735_bib38","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.nbd.2010.05.027","article-title":"Palmitoylation and function of glial glutamate transporter-1 is reduced in the YAC128 mouse model of Huntington disease","volume":"40","author":"Huang","year":"2010","journal-title":"Neurobiol Dis"},{"key":"10.1124\/jpet.121.000735_bib39","doi-asserted-by":"crossref","first-page":"114427","DOI":"10.1016\/j.bcp.2021.114427","article-title":"Optineurin deletion disrupts metabotropic glutamate receptor 5-mediated regulation of ERK1\/2, GSK3\u03b2\/ZBTB16, mTOR\/ULK1 signaling in autophagy","volume":"185","author":"Ibrahim","year":"2021","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.121.000735_bib40","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1527-3458.2007.00024.x","article-title":"The preclinical properties of a novel group II metabotropic glutamate receptor agonist LY379268","volume":"13","author":"Imre","year":"2007","journal-title":"CNS Drug Rev"},{"key":"10.1124\/jpet.121.000735_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0169-328X(98)00040-0","article-title":"Microglia-specific localisation of a novel calcium binding protein, Iba1","volume":"57","author":"Ito","year":"1998","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1124\/jpet.121.000735_bib42","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0014-2999(99)00397-0","article-title":"Neuroprotection by metabotropic glutamate receptor agonists: LY354740, LY379268 and LY389795","volume":"377","author":"Kingston","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.121.000735_bib43","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.tig.2004.01.008","article-title":"Huntingtin-protein interactions and the pathogenesis of Huntington\u2019s disease","volume":"20","author":"Li","year":"2004","journal-title":"Trends Genet"},{"key":"10.1124\/jpet.121.000735_bib44","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/ejn.12383","article-title":"Stimulating ERK\/PI3K\/NF\u03baB signaling pathways upon activation of mGluR2\/3 restores OGD-induced impairment in glutamate clearance in astrocytes","volume":"39","author":"Lin","year":"2014","journal-title":"Eur J Neurosci"},{"key":"10.1124\/jpet.121.000735_bib45","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes","volume":"72","author":"MacDonald","year":"1993","journal-title":"Cell"},{"key":"10.1124\/jpet.121.000735_bib46","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1056\/NEJM198611133152006","article-title":"Huntington\u2019s disease. Pathogenesis and management","volume":"315","author":"Martin","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.121.000735_bib47","doi-asserted-by":"crossref","first-page":"e49838","DOI":"10.1371\/journal.pone.0049838","article-title":"Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington\u2019s disease: zQ175","volume":"7","author":"Menalled","year":"2012","journal-title":"PLoS One"},{"key":"10.1124\/jpet.121.000735_bib48","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0028-3908(01)00044-2","article-title":"Anti-epileptic activity of group II metabotropic glutamate receptor agonists (--)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY379268) and (--)-2-thia-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY389795)","volume":"41","author":"Moldrich","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.121.000735_bib49","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1021\/jm980616n","volume":"42","author":"Monn","year":"1999","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.121.000735_bib50","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.niox.2018.12.002","article-title":"Age- and sex-related changes in cortical and striatal nitric oxide synthase in the Q175 mouse model of Huntington\u2019s disease","volume":"83","author":"Padovan-Neto","year":"2019","journal-title":"Nitric Oxide"},{"key":"10.1124\/jpet.121.000735_bib51","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/nm1632","article-title":"Activation of mGlu2\/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial","volume":"13","author":"Patil","year":"2007","journal-title":"Nat Med"},{"key":"10.1124\/jpet.121.000735_bib52","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrneurol.2010.17","article-title":"Microglia in neurodegenerative disease","volume":"6","author":"Perry","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"10.1124\/jpet.121.000735_bib53","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s12640-019-0003-y","article-title":"The Role of PI3K\/Akt and ERK in Neurodegenerative Disorders","volume":"35","author":"Rai","year":"2019","journal-title":"Neurotox Res"},{"key":"10.1124\/jpet.121.000735_bib54","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1212\/WNL.57.5.920","article-title":"Objective assessment of progression in Huntington\u2019s disease: a 3-year follow-up study","volume":"57","author":"Reilmann","year":"2001","journal-title":"Neurology"},{"key":"10.1124\/jpet.121.000735_bib55","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.nbd.2012.03.025","article-title":"The group 2 metabotropic glutamate receptor agonist LY379268 rescues neuronal, neurochemical and motor abnormalities in R6\/2 Huntington\u2019s disease mice","volume":"47","author":"Reiner","year":"2012","journal-title":"Neurobiol Dis"},{"key":"10.1124\/jpet.121.000735_bib56","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1093\/hmg\/ddt598","article-title":"Metabotropic glutamate receptor 5 knockout promotes motor and biochemical alterations in a mouse model of Huntington\u2019s disease","volume":"23","author":"Ribeiro","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1124\/jpet.121.000735_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12035-010-8153-1","article-title":"Huntington\u2019s disease and Group I metabotropic glutamate receptors","volume":"43","author":"Ribeiro","year":"2011","journal-title":"Mol Neurobiol"},{"key":"10.1124\/jpet.121.000735_bib58","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.phrs.2016.11.013","article-title":"Metabotropic glutamate receptors and neurodegenerative diseases","volume":"115","author":"Ribeiro","year":"2017","journal-title":"Pharmacol Res"},{"key":"10.1124\/jpet.121.000735_bib59","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/nn1134","article-title":"PI3 kinase enhancer-Homer complex couples mGluRI to PI3 kinase, preventing neuronal apoptosis","volume":"6","author":"Rong","year":"2003","journal-title":"Nat Neurosci"},{"key":"10.1124\/jpet.121.000735_bib60","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1750-1172-5-40","article-title":"Huntington\u2019s disease: A clinical review","volume":"5","author":"Roos","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"10.1124\/jpet.121.000735_bib61","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.brainres.2004.06.005","article-title":"The metabotropic glutamate receptor 5 antagonist MPEP and the mGluR2 agonist LY379268 modify disease progression in a transgenic mouse model of Huntington\u2019s disease","volume":"1019","author":"Schiefer","year":"2004","journal-title":"Brain Res"},{"key":"10.1124\/jpet.121.000735_bib62","first-page":"40","article-title":"Considering sex as a biological variable will require a global shift in science culture","volume":"5","author":"Shansky","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"10.1124\/jpet.121.000735_bib63","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1097\/WNR.0b013e32832e34ee","article-title":"Distinct neuroinflammatory profile in post-mortem human Huntington\u2019s disease","volume":"20","author":"Silvestroni","year":"2009","journal-title":"Neuroreport"},{"key":"10.1124\/jpet.121.000735_bib64","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.1093\/hmg\/ddu166","article-title":"Progressive axonal transport and synaptic protein changes correlate with behavioral and neuropathological abnormalities in the heterozygous Q175 KI mouse model of Huntington\u2019s disease","volume":"23","author":"Smith","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1124\/jpet.121.000735_bib65","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1042\/bj3030701","article-title":"Mitogen inactivation of glycogen synthase kinase-3 \u03b2 in intact cells via serine 9 phosphorylation","volume":"303","author":"Stambolic","year":"1994","journal-title":"Biochem J"},{"key":"10.1124\/jpet.121.000735_bib66","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1016\/j.celrep.2017.02.075","article-title":"\u03b2-Arrestin2 couples metabotropic glutamate receptor 5 to neuronal protein synthesis and is a potential target to treat fragile X","volume":"18","author":"Stoppel","year":"2017","journal-title":"Cell Rep"},{"key":"10.1124\/jpet.121.000735_bib67","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1093\/brain\/awm044","article-title":"Microglial activation in presymptomatic Huntington\u2019s disease gene carriers","volume":"130","author":"Tai","year":"2007","journal-title":"Brain"},{"key":"10.1124\/jpet.121.000735_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1471-4159.2006.04208.x","article-title":"Regulation of mitogen-activated protein kinases by glutamate receptors","volume":"100","author":"Wang","year":"2007","journal-title":"J Neurochem"},{"key":"10.1124\/jpet.121.000735_bib69","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0006-8993(94)91320-X","article-title":"Glutamate receptor expression in rat striatum: effect of deafferentation","volume":"647","author":"W\u00fcllner","year":"1994","journal-title":"Brain Res"},{"key":"10.1124\/jpet.121.000735_bib70","doi-asserted-by":"crossref","first-page":"e06734","DOI":"10.7554\/eLife.06734","article-title":"G-protein-coupled receptors regulate autophagy by ZBTB16-mediated ubiquitination and proteasomal degradation of Atg14L","volume":"4","author":"Zhang","year":"2015","journal-title":"eLife"},{"key":"10.1124\/jpet.121.000735_bib71","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1002\/jnr.22103","article-title":"N-methyl-D-aspartate-stimulated ERK1\/2 signaling and the transcriptional up-regulation of plasticity-related genes are developmentally regulated following in vitro neuronal maturation","volume":"87","author":"Zhou","year":"2009","journal-title":"J Neurosci Res"},{"key":"10.1124\/jpet.121.000735_bib72","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3389\/fneur.2020.00571","article-title":"Gender differences in non-sex linked disorders: insights from Huntington\u2019s disease","volume":"11","author":"Zielonka","year":"2020","journal-title":"Front Neurol"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524271226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524271226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.121.000735","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T14:03:51Z","timestamp":1739973831000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524271226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0022356524271226"],"URL":"https:\/\/doi.org\/10.1124\/jpet.121.000735","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabotropic Glutamate Receptor 2\/3 Activation Improves Motor Performance and Reduces Pathology in Heterozygous zQ175 Huntington Disease Mice","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.121.000735","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}